Pay in 4 interest-free payments of $6.78 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
Food and Drug Administration on Thursday voted to place a widely used peptide called BPC-157 on a list that would allow broader pharmacy compounding
The half-life means the drug accumulates to steady state over four to five weeks at a given dose
, , ,
Typical actives include metronidazole (antibiotic), azelaic acid, ivermectin (anti-parasitic), and niacinamide (anti-inflammatory and skin-soothing)
BPC-157 is also not a specifically named substance on the World Anti-Doping Agency (WADA) Prohibited List, although athletes should never assume that absence from a named list equals clearance, since broad catch-all categories can apply
Advertisement Article continues below this ad In addition to pain, an abnormal increase in red blood cells, a runny nose, chest pain, a swollen tongue, and fever are additional adverse reactions that may occur after the injection
US$ 23.97
US$ 22.35
US$ 29.62
US$ 29.62
US$ 24.91
US$ 26.41
US$ 23.66
US$ 25.33
US$ 21.31
